Metformin and Muscle in Insulin-resistant Older Veterans
Status:
Completed
Trial end date:
2018-08-31
Target enrollment:
Participant gender:
Summary
Sarcopenia is the loss of muscle mass, strength and function with aging and is associated
with increased disability, falls and fractures. Older adults with diabetes and prediabetes
are insulin resistant and have a higher risk of developing sarcopenia. This study examines
the use of metformin, an antidiabetic drug, for preventing the development of sarcopenia in
older adults with prediabetes.